Tylenol Liver Injury Lawsuit MDL Established
After oral arguments were presented during a hearing last month, the U.S. Judicial Panel on Multidistrict Litigation announced this week that all Tylenol liver injury lawsuits filed throughout the federal court system will be consolidated for pretrial proceedings as part of a Tylenol MDL.
Complaints filed in U.S. District Courts throughout the country will be transferred to the Eastern District of Pennsylvania in Philadelphia, where they will be coordinated for discovery and any early “bellwether” trials before the Honorable Lawrence F. Stengel, who is already presiding over a number of the cases.
As we explained in a post earlier this year, an MDL is managed in a manner similar to how a Tylenol class action would proceed. However, there are important differences and each lawsuit still remains an individual case where the plaintiff must establish that inadequate warnings were provided about the risk of liver damage or liver failure, and that the failure to warn was the cause of the plaintiff’s liver injury.
There are currently more than two dozen lawsuits filed throughout the federal court system that allege individuals suffered severe and sometimes fatal liver injury from Tylenol side effects. However, as new cases are filed in the coming months and years, this number is expected to increase.
The product liability lawyers at Saiontz & Kirk, P.A. are continuing to review potential claims for individuals who suffered a liver injury or liver failure after using Tylenol, and it is possible that hundreds, if not thousands of lawsuits will eventually be filed.
All cases are viewed by our Tylenol lawyers on a contingency fee basis, which means that there are no attorneys fees or expenses unless a recovery is obtained by our clients.
To review a potential case for yourself, a friend or family member, request a free consultation and claim evaluation.